Merck officially opened its €150m filtration manufacturing facility at Blarney Business Park in Cork last month. The Blarney facility is part of Merck’s largest life science investment to date in ...

The acquisition will expand MilliporeSigma's downstream processing portfolio with advanced Protein A chromatography capabilities.

Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutionsJSR’s ...

Strengthens 90-year legacy of partnership between MilliporeSigma and WashU to accelerate scientific progress Strategic academic-industry alliance aims to build robust Research & Development talent ...

Strategic academic-industry alliance aims to build robust Research & Development talent pipeline Reinforces MilliporeSigma’s long-standing commitment to St. Louis ST. LOUIS, July 24, 2025--(BUSINESS ...

While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...